Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

For example, Nohla Therapeutics is using the Karius Test to detect subclinical infection in a phase 2 study of acute myeloid leukemia patients with chemotherapy-induced neutropenia. “Patients ...

Late-onset neutropenia (LON) is emerging as a common ... The mechanisms of LON seem to be multifactorial and are related to rituximab-induced B lymphopenia. LON is self-limited in the majority ...